Concepedia

Keiko Kasutani

KK

Statistics

Publications

5

Citations

516

H-Index

5

Active since

1996

Affiliations

Chugai Pharma (United States)(Current)

The University of Osaka

Keiko Kasutani is an author at Chugai Pharma (United States) specializing in immunology, inflammation, and cytokine biology.

Publications per year

1996–2016

5

Publications

5

Tocilizumab inhibits signal transduction mediated by both mIL-6R and sIL-6R, but not by the receptors of other members of IL-6 cytokine family

Masahiko Mihara, Keiko Kasutani, Makoto Okazaki et al. · International Immunopharmacology · 2005 · 323 citations

Life Sciences, Immunology, Pharmacology +14

Anti‐<scp>IL</scp>‐31 receptor antibody is shown to be a potential therapeutic option for treating itch and dermatitis in mice

Keiko Kasutani, Etsuko Fujii, Satoko Ohyama et al. · British Journal of Pharmacology · 2014 · 73 citations · Full text

Medicine, Dermatology, Immunology +17

Cynomolgus monkey model of interleukin‐31‐induced scratching depicts blockade of human interleukin‐31 receptor A by a humanized monoclonal antibody

Sohei Oyama, Hidetomo Kitamura, Taichi Kuramochi et al. · Experimental Dermatology · 2016 · 59 citations · Full text

Medicine, Dermatology, Immunology +17

Requirement for Cooperative Interaction of Interleukin-6 Responsive Element Type 2 and Glucocorticoid Responsive Element in the Synergistic Activation of Mouse Metallothionein-I Gene by Interleukin-6 and Glucocorticoid

Keiko Kasutani, Norio Itoh, Masako Kanekiyo et al. · Toxicology and Applied Pharmacology · 1998 · 34 citations

Life Sciences, Cell Biology, Immunology +13

Blocking effect of anti-mouse interleukin-6 monoclonal antibody and glucocorticoid receptor antagonist, RU38486, on metallothionein-inducing activity of serum from lipopolysaccharide-treated mice

Norio Itoh, Keiko Kasutani, Norio Muto et al. · Toxicology · 1996 · 27 citations

Medicine, Immunology, Pharmacology +10

1–5 of 5